Kidney Cancer Coverage from Every Angle

Thomas Powles, MD, on Atezolizumab vs Chemotherapy in Urothelial Carcinoma

Posted: Monday, February 12, 2018

Thomas Powles, MD, of Barts Cancer Institute, discusses phase III study findings on atezolizumab vs chemotherapy in platinum-treated locally advanced or metastatic urothelial carcinoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.